Résultats de la recherche
10
Tout
Daxor's Blood Volume Analysis Uncovers Hidden Heart Failure Subtype in Nearly 1 in 5 Patients, Enabling Targeted Treatment
14 févr. 2025 08h00 HE
|
Daxor Corporation
Case Reports in the Journal of the American College of Cardiology Underscore the Critical Role of Blood Volume Analysis in Optimizing Heart Failure Treatment Oak Ridge, TN, Feb. 14, 2025 (GLOBE...
New Multicenter Study Highlights Utility of Daxor’s Blood Volume Analysis in Heart Failure Care
13 févr. 2025 08h00 HE
|
Daxor Corporation
Research Published in the Prestigious Journal of Cardiac Failure From Three Institutions Oak Ridge, TN, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood...
AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in congestive heart failure
18 avr. 2024 08h00 HE
|
Asklepios BioPharmaceutical, Inc. (AskBio)
Berlin, Germany, and Research Triangle Park, NC, USA, April 18, 2024 (GLOBE NEWSWIRE) -- Not intended for UK Media AB-1002 is being studied for the treatment of adults with non-ischemic...
Impulse Dynamics Announces Leadership Changes
19 sept. 2023 07h17 HE
|
Impulse Dynamics
MARLTON, N.J., Sept. 19, 2023 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure, announced new leadership...
Daxor Corporation to Showcase the Benefits of BVA-100® Guided Care at the American Association of Heart Failure Nurses (AAHFN) 19th Annual Meeting
20 juin 2023 08h00 HE
|
Daxor Corporation
Oak Ridge, TN, June 20, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will exhibit at the American...
Daxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offering
22 mai 2023 08h30 HE
|
Daxor Corporation
Oak Ridge, TN, May 22, 2023 (GLOBE NEWSWIRE) -- DAXOR CORPORATION (Nasdaq: DXR) (“Daxor”, or the “Company”), the global leader in blood volume measurement technology, today announced the pricing of...
Impulse Dynamics Announces First Implant for CCM-D™ Clinical Trial
18 mai 2023 07h30 HE
|
Impulse Dynamics
MARLTON, N.J., May 18, 2023 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure, announced the completion of the...
Impulse Dynamics Announces 9,000th Patient Milestone Achieved With CCM® Therapy for Heart Failure
15 mai 2023 14h09 HE
|
Impulse Dynamics
MARLTON, N.J., May 15, 2023 (GLOBE NEWSWIRE) -- Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today a worldwide...
New Studies Presented at the 43rd International Society for Heart and Lung Transplant Validate the Applicability of the BVA-100® Blood Test for Patients with Advanced Heart Failure
20 avr. 2023 08h00 HE
|
Daxor Corporation
Study Demonstrates BVA Provides More Accurate Congestion Measurement in Challenging Patient Populations Oak Ridge, TN, April 20, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global...
New Data Advocates Shift to In-Home Healthcare, Casana Appoints VP of Research to Enhance Product Development
29 mars 2023 09h00 HE
|
Casana Care, Inc.
ROCHESTER, N.Y., March 29, 2023 (GLOBE NEWSWIRE) -- Today, Casana - the industry leader in monitoring heart health through smart toilets - announced that data from clinical study participants...